BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Detailed News
Back
Indrayani Biotech consolidated net profit declines 25.41% in the September 2025 quarter
16-Dec-25   07:38 Hrs IST

Net profit of Indrayani Biotech declined 25.41% to Rs 0.91 crore in the quarter ended September 2025 as against Rs 1.22 crore during the previous quarter ended September 2024. Sales rose 16.68% to Rs 35.95 crore in the quarter ended September 2025 as against Rs 30.81 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales35.9530.81 17
OPM %6.8216.59 -
PBDT2.363.99 -41
PBT1.061.20 -12
NP0.911.22 -25

Powered by Capital Market - Live News
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)